Cited by 124Genetics and Neurodevelopmental DisordersProtein Tyrosine PhosphatasesGenomics and Rare Diseases

B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability

Open access
Houge, Gunnar, Haesen, Dorien, Vissers, Lisenka E.L.M., Mehta, Sarju, Parker, Michael J., Wright, Michael, Vogt, Julie, McKee, Shane +21 more·2015·Journal of Clinical Investigation

Abstract

Here we report inherited dysregulation of protein phosphatase activity as a cause of intellectual disability (ID). De novo missense mutations in 2 subunits of serine/threonine (Ser/Thr) protein phosphatase 2A (PP2A) were identified in 16 individuals with mild to severe ID, long-lasting hypotonia, epileptic susceptibility, frontal bossing, mild hypertelorism, and downslanting palpebral fissures. PP2A comprises catalytic (C), scaffolding (A), and regulatory (B) subunits that determine subcellular anchoring, substrate specificity, and physiological function. Ten patients had mutations within a highly conserved acidic loop of the PPP2R5D-encoded B56δ regulatory subunit, with the same E198K mutation present in 6 individuals. Five patients had mutations in the PPP2R1A-encoded scaffolding Aα subunit, with the same R182W mutation in 3 individuals. Some Aα cases presented with large ventricles, causing macrocephaly and hydrocephalus suspicion, and all cases exhibited partial or complete corpus callosum agenesis. Functional evaluation revealed that mutant A and B subunits were stable and uncoupled from phosphatase activity. Mutant B56δ was A and C binding-deficient, while mutant Aα subunits bound B56δ well but were unable to bind C or bound a catalytically impaired C, suggesting a dominant-negative effect where mutant subunits hinder dephosphorylation of B56δ-anchored substrates. Moreover, mutant subunit overexpression resulted in hyperphosphorylation of GSK3β, a B56δ-regulated substrate. This effect was in line with clinical observations, supporting a correlation between the ID degree and biochemical disturbance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci79860

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Dysregulation of PP2A is strongly associated with several diseases, including Alzheimer's disease, intellectual disability, autoimmune disease, diabetes and diverse cancers.

    “Thus, it is not surprising that dysregulation of PP2A has been strongly associated with several disease states, including Alzheimer's disease, intellectual disability (ID), autoimmune disease, diabetes and diverse cancers [1][2][3][4][5].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 47 · Cited by 124

Research works printed but not linked: 1

  1. Chen W, Arroyo JD, Timmons JC, Posse- mato R, Hahn WC. Cancer-associated PP2A Aalpha subunits induce functional haploin- sufficiency and tumorigenicity. Cancer Res. 2005;65(18):8183-8192.

Authors
Houge, G., Haesen, D., Vissers, L. E. L. M., Mehta, S., Parker, M. J., Wright, M., Vogt, J., McKee, S., Tolmie, J. L., Cordeiro, N., Kleefstra, T., Willemsen, M. H., Reijnders, M. R. F., Berland, S., Hayman, E., Lahat, E., Brilstra, E. H., van Gassen, K. L. I., Zonneveld-Huijssoon, E., de Bie, C. I., Hoischen, A., Eichler, E. E., Holdhus, R., Steen, V. M., Døskeland, S. O., Hurles, M. E., FitzPatrick, D. R., study, T. D. D. D. (., & Janssens, V.
Affiliations
  • Haukeland University Hospital (NO)
  • KU Leuven (BE)
  • Radboud University Nijmegen (NL)
  • Addenbrooke's Hospital (GB)
  • Sheffield Children's Hospital (GB)
  • Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
  • Birmingham Women's Hospital (GB)
  • Belfast City Hospital (GB)
  • NHS Greater Glasgow and Clyde (GB)
  • NHS Ayrshire and Arran (GB)
  • Assaf Harofeh Medical Center (IL)
  • University Medical Center Utrecht (NL)
  • University of Washington (US)
  • University of Bergen (NO)
  • Wellcome Sanger Institute (GB)
  • Institute of Genetics and Cancer (GB)
Corresponding author
  • Houge, Gunnar
  • Haesen, Dorien
  • the Deciphering Developmental Disorders (DDD) study
Venue
Journal of Clinical Investigation
Published
2015-07-13
Volume
125
Issue
8
Pages
3051-3062
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2102290245
Cited by
124
References
47
Citations by year
2026: 6 · 2025: 16 · 2024: 16 · 2023: 15 · 2022: 15 · 2021: 13 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 1
FWCI
5.50
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Lirias (KU Leuven) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Wellcome Trust (WT 098051)
  • Australian Government
  • National Institute for Health and Care Research
  • ZonMw
  • Belgian Federal Science Policy Office (P7/13)
  • Fonds Wetenschappelijk Onderzoek (P7/13)
  • KU Leuven (P7/13)
  • Helse Vest
  • Vlaamse regering
  • National Institutes of Health
  • National Institute of Mental Health (R01MH101221)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083091)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
intellectual disability, protein phosphatase 2A, PPP2R5D, PPP2R1A, de novo missense variant, dominant negative effect, agenesis of the corpus callosum, hydrocephalus, macrocephaly, hypotonia, frontal bossing, hypertelorism
MeSH terms
Glycogen Synthase Kinase 3 beta, Adolescent, Adult, Mental Disorders, Child, Child, Preschool, Corpus Callosum, Female, Humans, Infant, Male, Middle Aged, Phosphorylation, Protein Structure, Secondary, Protein Structure, Tertiary, Amino Acid Substitution, Mutation, Missense, Glycogen Synthase Kinase 3, Protein Phosphatase 2, Agenesis of Corpus Callosum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review